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ABSTRACT Human replication protein A (RP-A) is a
three-subunit protein that is required for simian virus 40
(SV40) replication in vitro. The trypanosome homologue of
RP-A has been purified from Crithidiafasciculat. It is a 1:1:1
complex of three polypeptides of 51, 28, and 14 kDa, binds
single-stranded DNA via the large subunit, and is localized
within the nucleus. C. fasciculdta RP-A substitutes for human
RP-A in the large tumor antigen-dependent unwinding of the
SV40 origin of replication and stimulates both DNA synthesis
and DNA priming by human DNA polymerase a/primase, but
it does not support efficient SV40DNA replication in vitro. This
extraordinary conservation of structure and function between
human and trypanosome RP-A suggests that the mechanism of
DNA replication, at both the initiation and the elongation level,
is conserved in organisms that diverged from the main eukary-
otic lineage very early in evolution.
Trypanosomes are protozoan parasites of considerable med-
ical and economic importance; they cause serious disease in
humans and livestock. They are characterized by the presence
ofa kinetoplast, a massive network ofcatenated circularDNA
molecules located at the base ofthe flagellum within the single
mitochondrion of these cells. Trypanosomes diverged from
the major eukaryotic lineage very early in the evolutionary
history of eukaryotic cells relative to the separation of the
"higher" evolutionary groups, the plants, animals, and fungi
(1, 2). Studies of transcription in trypanosomes have revealed
a number of unusual features, including trans-splicing, a
process by which discontinuously synthesized precursor
RNAs are spliced to yield mature messenger RNAs, and RNA
editing, which involves the insertion and deletion of uridine
residues in mitochondrial RNA transcripts. Studies of DNA
replication in trypanosomes have focused mainly on the ki-
netoplast minicircle DNA, a molecule unique among mito-
chondrial DNAs for its high copy number and its cell cycle-
regulated replication (for review, see refs. 3 and 4). The
biochemical mechanism and the regulation of nuclear DNA
replication in trypanosomes are poorly understood. Only one
protein expected to be involved in nuclear DNA replication
has been purified to homogeneity from a trypanosome, a type
I topoisomerase from Crithidiafasciculata (5). Two RNase H
activities in crude extracts of C. fasciculata have been de-
scribed (6) and seem to be similar to the class I and class II
RNase H enzymes of higher eukaryotes. Two DNA polymer-
ases have been partially purified from C. fasciculata and
Trypanosoma brucei (7, 8). These proteins are similar toDNA
polymerases a and ( of higher eukaryotes, but they were
found to differ from their mammalian homologues in their
response to several DNA polymerase inhibitors (7). Little else
is known of other proteins involved in chromosomal DNA
replication in trypanosomes and their biochemical proper-
ties-for example, whether they are homologous to known
replication proteins from higher eukaryotes, whether they are
regulated in a cell cycle-dependent fashion, and whether their
properties can be exploited as targets for therapeutic drugs.
Neither proteins involved in initiation ofDNA replication nor
proteins involved in the cell cycle regulation of replication
have been identified.
Replication protein A [RP-A; also called RF-A or human
single-stranded DNA-binding protein (SSB)] was first isolated
from a protein fraction ofhuman cells required for the in vitro
replication of simian virus 40 (SV40) (9-11). It is a three-
subunit, multifunctional SSB involved in both the initiation
and elongation phases of SV40 replication. With topoisomer-
ase I and the SV40 large tumor antigen (T-Ag), RP-A partic-
ipates in the unwinding ofthe SV40 origin ofreplication during
the initiation of DNA replication (12-14). RP-A stimulates
DNA synthesis by DNA polymerases a and a (15-17), sug-
gesting that RP-A functions in the elongation phase of DNA
replication in vitro. RP-A is present in the yeast Saccharomy-
ces cerevisiae (18), indicating that its activity is evolutionarily
conserved. In both yeast and human cells, RP-A is posttrans-
lationally modified by phosphorylation of the middle subunit
in a cell cycle-dependent manner (19), suggesting a role for
RP-A in the cell cycle regulation ofDNA replication. Extracts
from cells in G1 phase, the phase in which RP-A is unphos-
phorylated, have lower activity in unwinding the SV40 origin
of replication and are 10 times less efficient at initiating SV40
replication, when compared to extracts from cells in S or G2
phase, the phases during which RP-A is phosphorylated (20).
A link between a regulatory role for RP-A and the cell cycle
control machinery is suggested by the observation that G1
extracts can be activated by a fraction that contains a kinase
homologous to the p34cdc2 kinase (21). The genes encoding the
three subunits of RP-A in yeast are all essential for viability
(22), indicating the essential nature of the functions of RP-A.
In this report, the identification and characterization of the
trypanosome homologue of RP-A are described.
MATERIALS AND METHODS
CeU Growth. C. fasciculata Cf-Cl was grown, harvested,
and stored frozen at -750C as described (23).
Purification of RP-A. RP-A was purified from C. fascicu-
lata as described for the purification ofRP-A from yeast (18),
with several modifications. Fifty grams offrozen cells (-5 X
1011 cells) was thawed in 250 ml of 50 mM Hepes (pH 7.5), 10
mM EDTA, 0.5 M NaCl, 2.5 mM 2-mercaptoethanol, leu-
peptin (2 ug/ml), pepstatin A (1 ug/ml), 1 mM phenylmeth-
ylsulfonyl fluoride, and 10 mM benzamidine. After homog-
enization with a motor-driven Teflon pestle, the lysate was
stirred for 30 min at 0C. The lysate was clarified by centrif-
ugation in a Beckman Ti45 rotor (40,000 rpm for 30 min at
20C). The supernatant was filtered through Miracloth and
Abbreviations: RP-A, replication protein A; SV40, simian virus 40;
ssDNA, single-stranded DNA; SSB, single-stranded DNA-binding
protein; T-Ag, large tumor antigen.
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centrifuged for an additional 90 min at 40,000 rpm at 20C in
a Ti45 rotor. The clear amber supernatant was loaded onto a
2.5 x 3 cm single-stranded DNA (ssDNA)-celiulose (Sigma)
column equilibrated in 25 mM Hepes (pH 7.5), 1 mM EDTA,
10% (vol/vol) glycerol, 0.02% (wt/vol) Brij 58, 2.5 mM
2-mercaptoethanol, leupeptin (1 ,ug/ml), pepstatin A (0.5
,ug/ml), and 0.25 mM phenylmethylsulfonyl fluoride (buffer
A) containing 0.5 M NaCl. The column was washed with 3 vol
of buffer A containing 0.75 M NaCl, and the protein was
eluted with buffer A containing 1.5 M NaCl and 50%o (vol/vol)
ethylene glycol. Protein-containing fractions were pooled
and dialyzed against 25 mM imidazole hydrochloride (pH
7.5), 0.1 mM EDTA, 10%6 glycerol, 0.02% Brij 58, 2.5 mM
2-mercaptoethanol, leupeptin (1 ,g/ml), pepstatin A (0.5
pg/ml), and 0.25 mM phenylmethylsulfonyl fluoride (buffer
B) containing 10 mM NaCl. The dialysate was clarified by
passage through a 0.2-,um nitrocellulose filter and applied to
a Mono Q column (HR 5/5; Pharmacia). The column was
washed with S ml of buffer B containing 10mM NaCl, and the
protein was eluted with a 20-ml linear gradient from 10 mM
to 400 mM NaCl in buffer B. This procedure yielded 300 I&g
of RP-A, as determined by a modified Bradford assay (24),
using bovine serum albumin as a standard. The preparation
was 94% homogeneous as judged by scanning densitometry
of Coomassie brilliant blue-stained polyacrylamide gels. The
molar ratio of the subunits was also determined by densi-
tometry.
Reaction Conditions. SV40 origin unwinding assays (25 ,ul)
were performed as described (13), with incubation at 37°C for
30 min. Reactions were terminated, and reaction mixtures
were processed for electrophoresis as described (15) and
electrophoresed for 12 hr at 25 V through a 1.5% agarose gel
in 40 mM Tris acetate, pH 7.5/1 mM EDTA. DNA was
detected by staining for 1 hr in ethidium bromide (0.5 ,ug/ml)
followed by visualization with a UV transilluminator.
Binding of ssDNA by RP-A subunits was investigated by
protein-DNA blotting of RP-A-containing fractions by using
thermally denatured, 32P-labeled pUC19 DNA as a probe, as
described (25).
SV40 replication reactions were performed by using puri-
fied T-Ag, topoisomerases I and II, replication factor C,
proliferating-cell nuclear antigen, and fraction IIA, as de-
scribed (13).
DNA polymerase stimulation assays were performed with
polymerase a/primase (333 ng/ml) with poly(dA)-oligo(dT)
as template-primer DNA (17). Primase stimulation assays
contained 20 mM Tris (pH 7.8), 8 mM MgCI2, 4% glycerol, 4
mM dithiothreitol, bovine serum albumin (0.5 mg/ml),
poly(dT) (0.1 mM nucleotide; average length of 300 nucleo-
tides) as template DNA, 0.5 mM ATP, 50 ,uM [32P]dATP
(3000 cpm/pmol), polymerase a/primase (167 ng/ml), and
Escherichia coli DNA polymerase I Klenow fragment (10
units/mi).
Immunization Procedure. Purified RP-A (150 ,ug) in 0.5 ml
of phosphate-buffered saline (PBS; 20mM KPO4, pH 7.5/150
mM NaCl) was emulsified with 0.5 ml of 2x concentrated
RIBI adjuvant (Ribi Immunochem) in PBS and injected
subcutaneously into a female New Zealand White rabbit at
five sites. The rabbit was boosted on day 28 following the
same protocol and bled on day 38.
Immunoblots. Proteins were separated by SDS/PAGE (26)
and transferred to 0.2-,um pore size nitrocellulose filters in 25
mM Tris, 192 mM glycine, and 20% methanol (pH 8.3).
Filters were blocked in PBS plus 0.05% Tween 20 (PBST)
containing 2% (wt/vol) bovine serum albumin and 5% (vol/
vol) goat serum for 1 hr at 22°C. Filters were incubated in a
500-fold dilution of antiserum for 1.5 hr. washed three times
with PBST, incubated with a 5000-fold dilution of alkaline
phosphatase-conjugated goat anti-rabbit IgG antibody for 30
min, washed three times with PBST, and developed with
nitroblue tetrazolium and 5-bromo-4-chloro-3-indoylyl phos-
phate (Promega).
Immunocytochemistry. Immunolocalizations were per-
formed essentially as described (5), using a 200-fold dilution
of antiserum raised against C. fasciculata RP-A.
RESULTS
Purification of RP-A From the Trypanosomatid C. fascicu-
iota. The C. fasciculata homologue of RP-A was purified by
using ssDNA-cellulose and Mono Q column chromatogra-
phy. As is the case with RP-A from S. cerevisiae and human
cells, the protein from C.fasciculata bound tightly to ssDNA,
requiring greater than 0.75 M NaCl for elution. The Mono Q
column removed trace contaminants present after the ssDNA
column and concentrated the RP-A. Fig. la shows SDS/
PAGE analysis of each step in the purification and Mono Q
column fractions 1-10. The peak of C. fasciculata RP-A
eluted from the Mono Q column at 125 mM NaCI, in
fractions 5 and 6. These fractions contained three polypep-
tides with molecular masses of 51 kDa, 28 kDa, and 14 kDa
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FIG. 1. Cofractionation of C. fasciculata RP-A protein, ssDNA
binding activity, and SV40 origin unwinding activity. (a) SDS/PAGE
and Coomassie brilliant blue stain analysis of molecular mass mark-
ers (lane M; in kDa), the clarified extract (lane E), ssDNA-celiulose
eluate (lane S), Mono Q load (lane L), and Mono Q fractions 1-10
(lanes 1-10). The positions of the three RP-A subunits are indicated
(p5l, p28, and p14). (b) ssDNA binding activity ofMono Q fractions
1-10 analyzed by protein-DNA blotting of these fractions, using
32P-labeled ssDNA as a probe. The position of the large subunit of
RP-A is indicated (p51). (c) SV40 origin unwinding assays containing
T-Ag, topoisomerase I, SV40 origin-containing plasmid, and no
RP-A (lane 0), 500 ng of human RP-A (lane H), 500 ng of E. coli
ssDNA binding protein (lane C), or Mono Q fractions 1-10 (lanes
1-10). The position of the underwound form is indicated (U).
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(p5l, p28, and p14), in a molar ratio of 0.87:1.0:0.98. The
three-subunit structure of RP-A in yeast and human cells is
conserved in C. fasciculata, although the molecular masses
of the subunits differ [69 kDa, 36 kDa, and 13 kDa for yeast
(18); 70 kDa, 34 kDa, and 11 kDa for human (10)].
Identification of the Subunit That Binds to ssDNA. For yeast
and human RP-A, the large subunit is responsible for binding
ssDNA (18, 25). The subunit ofC.fasciculata RP-A that binds
ssDNA was identified by blotting SDS/PAGE-separated sam-
ples of the ssDNA-cellulose pool, Mono Q load, and Mono Q
fractions 1-10 onto a nitrocellulose filter and probing with
32P-labeled ssDNA (Fig. lb). This analysis demonstrated that
only the large subunit of C. fasciculata RP-A (p5l) binds
ssDNA and that the ssDNA binding activity cofractionates
with the three RP-A polypeptides on the Mono Q column.
C.fasciculata RP-A Substitutes forHuman RP-A in Unwind-
ing the SV40 Origin of Replication. In the presence of T-Ag,
topoisomerase I, and RP-A, SV40 DNA is converted to a
topologically underwound form, which is an early interme-
diate in the initiation of SV40 DNA replication, prior to
primer formation and origin-specific DNA synthesis (12, 13,
27). Although human RP-A is required for SV40 DNA
replication, yeast RP-A (18), E. coli SSB (12), adenovirus
DNA-binding protein, and herpes simplex virus infected-cell
polypeptide 8 (15) can each substitute for human RP-A in the
formation of the underwound form, in the absence of DNA
synthesis. To determine whether C. fasciculata RP-A could
function in this reaction, unwinding assays were performed
using Mono Q column fractions instead ofhuman RP-A (Fig.
ic). The same Mono Q fractions that contain C. fasciculata
RP-A and ssDNA binding activity (fractions 5 and 6) also
substituted for human RP-A in unwinding the SV40 origin of
replication to produce the underwound form of DNA.
Identification of RP-A Subunits in Fresh C. fasciculata
Lysates. The molecular masses of the subunits of C. fascic-
ulata RP-A differ from those found for yeast and human RP-A
subunits. To ensure that the purified RP-A represented the
intact form of each of the subunits, as found in vivo, samples
of purified C. fasciculata RP-A and fresh C. fasciculata
lysates were subjected to immunoblot analysis with an anti-
serum raised against purified C. fasciculata RP-A (Fig. 2).
The antiserum identifies polypeptides of 51 kDa and 28 kDa
in both the purified RP-A (lanes 1 and 2) and the cell lysate
(lane 3). Several polypeptides of >66 kDa are identified
faintly in the cell lysate, but are not seen when similar blots
are probed with antiserum that has been affinity purified
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FIG. 2. Immunoblot of purified RP-A and freshly lysed C.
fasciculata. Purified RP-A (20 ng, lane 1; 10 ng, lane 2) and C.
fasciculata lysed by boiling in SDS reducing buffer (3.8 x 106 cells;
lane 3) were electrophoresed in an SDS/15% polyacrylamide gel and
transferred to nitrocellulose. RP-A was detected by using antiserum
raised against purified C. fasciculata RP-A. The positions of molec-
ular mass markers (in kDa) are indicated.
using p51 (data not shown). The antiserum does not identify
p14 in any of the samples. Since the major forms of p51 and
p28 have the same molecular masses in freshly lysed cells as
they do in the purified samples, these likely represent the
intact subunits and not proteolytic degradation products,
despite their being smaller than the corresponding subunits of
human and yeast RP-A.
C. fasciculata RP-A is a Nuclear Protein. Human RP-A is
located almost exclusively in the nucleus (28). The intracel-
lular localization of C. fasciculata RP-A was determined by
immunofluorescence microscopy. Fixed C. fasciculata were
incubated with polyclonal rabbit antiserum raised against
purified RP-A. Bound antibody was then detected with a
fluorescein isothiocyanate-labeled secondary antibody. The
positions ofthe nuclear and kinetoplast (mitochondrial) DNA
were detected with the DNA-binding dye 4',6-diamidino-2-
phenylindole. Fig. 3a shows the staining of the nuclei and
kinetoplasts with 4',6-diamidino-2-phenylindole. Fig. 3b
shows fluorescein isothiocyanate staining of the same field of
cells. Anti-RP-A antibody is found exclusively in the nucleus
of each cell, indicating that C. fasciculata RP-A is a nuclear
protein, consistent with it functioning in chromosomal rep-
lication. Use of preimmune serum in place of anti-RP-A
antiserum produced no visible staining (not shown).
C. fascicuata RP-A Cannot Replace Human RP-A in the
SV40 DNA Replication Reaction. C. fasciculata RP-A was
tested for its ability to substitute for human RP-A in the in
vitro SV40 replication system reconstituted with purified
proteins and fraction IIA (Fig. 4a). In this reaction, saturating
concentrations of human RP-A (37.5 pSg/ml) yielded an
incorporation of 25.4 pmol of dAMP. Substituting C. fascic-
ulata RP-A at as much as 50 pug/ml yielded an incorporation
of only 1.9 pmol of dAMP, which is <10%6 of the incorpo-
ration seen with human RP-A. This level ofDNA synthesis
was similar to that seen when yeast RP-A or E. coli SSB was
substituted for human RP-A (3.5 and 2.5 pmol of dAMP
incorporated, respectively), but greater than the peak level of
synthesis seen with T4 gene 32 protein (0.3 pmol of dAMP
with T4 gene 32 protein at 50 Iug/ml).
The products of these SV40 replication reactions were
analyzed on a denaturing agarose gel (Fig. 4b). Ten-fold less
of the human RP-A-containing reaction mixtures was ana-
lyzed to compensate for the -10-fold greater synthesis in
these reactions. The products of the reactions containing
human RP-A (lanes 2-5) migrated as unit-length linear single-
stranded molecules or as form I molecules, with a smear of
DNA strands that are smaller than unit length. The products
of the reactions containing yeast RP-A Qanes 10-13) were
similar, but included strands of greater than unit length,
probably resulting from background repair synthesis. The
FIG. 3. Intracellular localization of RP-A using indirect immuno-
fluorescence. (a) 4',6-Diamidino-2-phenylindole-stained DNA struc-
tures. (b) Cells were treated with antiserum raised against purified C.
fasciculata RP-A, followed by a fluorescein isothiocyanate-labeled
second antibody. The positions of the nuclear DNA (N) and the
kinetoplast (mitochondrial) DNA (K) are indicated. (Bar = 5 Aum.)
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FIG. 4. C. fasciculata RP-A substitution in SV40 replication
reactions. (a) Human RP-A (-), yeast RP-A (A), C.fasciculata RP-A
(A), E. coli SSB (o), and T4 gene 32 protein (e) at 0-50 ,ug/ml were
incubated with optimized amounts of T-Ag, topoisomerase I, topo-
isomerase II, proliferating-cell nuclear antigen, replication factor C,
fraction 11A (which contains DNA polymerases a and 8 and matu-
ration factors), and SV40 origin-containing plasmid, and DNA syn-
thesis was measured. (b) Samples of the replication products were
analyzed on denaturing agarose gels. Reactions contained the fol-
lowing concentrations of the indicated proteins. Lanes: 1, 0 jtg/ml;
lanes 2, 6, 10, and 14, 50 .g/ml; lanes 3, 7, 11, and 15, 37.5 ;&g/ml;
lanes 4, 8, 12, and 16, 25 ;ig/ml; lanes 5, 9, 13, and 17, 12.5 j&g/ml.
For human RP-A (lanes 2-5), 10-fold less of the replication products
was analyzed than in all other lanes. The positions of unit-length
single-stranded linear molecules (SSL) and denatured form I mole-
cules (I) are indicated. hRP-A, human RP-A; cfRP-A, C.fasciculata
RP-A; yRP-A, yeast RP-A.
reactions with E. coli SSB (lanes 14-17) showed a larger
proportion of ssDNA molecules of greater than unit length.
In the C. fasciculata RP-A reactions (lanes 6-9), most of the
synthesis resulted in the production of these abnormal, long
single strands, with very little synthesis of unit-length single-
stranded linear molecules or of form I molecules. Thus C.
fasciculata RP-A substitutes poorly for human RP-A in SV40
DNA replication, yielding <10%o of the DNA synthesis seen
with human RP-A and resulting largely in the synthesis of
abnormally long DNA strands.
C. fascculata RP-A Stmulates Hu DNA Poymerase
a/Primase. Human RP-A stimulates DNA synthesis by
human DNA polymerase a/primase =5-fold, suggesting a
role for RP-A in the elongation phase of replication (15, 16).
This stimulation appears to be specific, since E. coli SSB, T4
gene 32 protein, adenovirus DNA-binding protein, and
herpes simplex virus infected-cell polypeptide 8, all ofwhich
are SSBs that stimulate their cognate DNA polymerases and
are required for DNA replication (29-32), fail to stimulate
human polymerase a (15). The effect of C. fasciculata RP-A
on DNA synthesis by human polymerase a was examined
(Fig. 5a). Under the conditions used, human RP-A at a
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FIG. 5. Stimulation of polymerase a/primase activity by C.
fasciculata RP-A. (a) DNA synthesis by human DNA polymerase
a/primase using poly(dA).oligo(dT) as primer-template DNA in the
presence of increasing concentrations of human RP-A (m), C. fas-
ciculata RP-A (A), SSB (o), or T4 gene 32 protein (e). (b) DNA
primase activity of human DNA polymerase a/primase measured
using poly(dT) as template DNA in the presence of increasing
concentrations ofhuman RP-A (m), C.fasciculata RP-A (A), SSB (o),
or T4 gene 32 protein (e).
concentration of 25 pug/ml stimulated DNA synthesis 4.2-
fold, and E. coli SSB and T4 gene 32 protein both inhibited
DNA synthesis slightly, all consistent with previous findings.
At 25 jug/ml, C. fasciculata RP-A stimulated DNA synthesis
by human polymerase a 2.1-fold, suggesting that it is capable
of specific interaction with a heterologous polymerase, al-
though with a lower efficiency than the cognate RP-A.
Stimulation of the primase activity of human DNA polymer-
ase a/primase was also investigated (Fig. Sb). Both human
and C. fasciculata RP-A stimulated primase activity; human
RP-A increased the activity 2.7-fold and C. fasciculata RP-A
increased the activity 2.5-fold, whereas E. coli SSB and T4
gene 32 protein had little effect. These results indicate that
the inability of C. fasciculata RP-A to substitute for human
RP-A in the SV40 replication reaction is not due to an
inability to stimulate human polymerase a/primase. Whereas
substituting C.fasciculata RP-A for human RP-A in the SV40
replication reaction reduced DNA synthesis 13.6-fold, the
same substitution in the polymerase stimulation assay re-
duced synthesis only 2-fold and had a negligible effect in the
primase stimulation assay. Further interactions between
RP-A and the other replication proteins must account for the
specific requirement for human RP-A in the SV40 replication
reaction, perhaps in a complex involved in initiation ofDNA
synthesis, between the origin-unwinding and elongation
phases of replication.
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DISCUSSION
A trypanosome homologue of the essential replication pro-
tein RP-A has been identified by several criteria. The protein,
as purified from C. fasciculata, binds tightly to ssDNA-
cellulose and is a 1:1:1 complex of three subunits. It binds
ssDNA via the largest subunit (p5l), is located in the nucleus,
functions in a SV40 origin unwinding assay, and stimulates
human DNA polymerase a/primase. Proteins that bind
tightly to ssDNA but do not function in eukaryotic nuclear
DNA replication either fail to substitute in the SV46 origin
unwinding assay [e.g., T4 gene 32 protein and calf thymus
protein UP1 (15)] or fail to stimulate human DNA polymerase
a/primase [e.g., E. coli SSB, adenovirus DNA-binding pro-
tein, and herpes simplex virus infected-cell polypeptide 8 (15,
16)]. One property of human RP-A that the C. fasciculata
protein does not share is the ability to support SV40 repli-
cation in vitro, a property that the yeast RP-A homologue also
lacks (18). This conservation of subunit structure and of
numerous activities indicates that the protein described here
represents the trypanosome homologue of RP-A.
The large subunit of RP-A from C. fasciculata is unusually
small, measuring 51 kDa, compared to 69 kDa for the yeast
subunit and 70 kDa for the human subunit. The molecular
mass of 51 kDa represents the intact large subunit, as
indicated by Western blot analysis of freshly lysed cells. One
function of the large subunit of yeast and human RP-A is the
binding of ssDNA. Protein-DNA blotting analysis of C.
fasciculata RP-A indicates that p51 retains this activity,
despite being significantly smaller than the yeast or human
large subunits. It will be of interest to determine whether a
particular domain is missing in the large subunit of C.
fasciculata RP-A and if so what the function of that domain
is in yeast and human cells.
C. fasciculata RP-A fails to substitute for human RP-A in
the SV40 replication reaction, despite functioning in the SV40
origin unwinding reaction, stimulating the primase activity of
human DNA polymerase a/primase to the same level as
human RP-A, and stimulating the polymerase activity of
polymerase a/primase to 50% of the level seen with human
RP-A. The reduction in polymerase a stimulation could be
more pronounced in the complete replication reaction, due to
interactions with other replication proteins and due to poly-
merase a's function in the initiation of leading-strand syn-
thesis (17, 33-35). Human RP-A interacts specifically with
T-Ag (36). The functional significance of this interaction is
suggested by the observation that human RP-A, the 70-kDa
subunit of human RP-A, and E. coli SSB all inhibit DNA
polymerase a/primase activity on an artificial replication
fork template, but only the inhibition by human RP-A can be
overcome by the addition of T-Ag (37). Absence of an
important interaction between C.fasciculata RP-A and T-Ag
might result in the inability of C. fasciculata RP-A to sub-
stitute for human RP-A in SV40 replication. Failure of C.
fasciculata RP-A to stimulate polymerase may also con-
tribute to its inactivity in SV40 replication, although this is
unlikely since stimulation of polymerase 8 by SSBs appears
to be nonspecific (15).
Nuclear DNA replication in trypanosomes is poorly under-
stood. The striking conservation of the subunit structure and
the multiple activities of RP-A in C. fasciculata suggest that
the basic DNA replication machinery found in higher eukary-
otes is conserved in organisms that diverged from the main
eukaryotic lineage very early in evolution. Proteins involved
in replication, particularly the DNA polymerases, represent
good targets for therapeutic drugs, and this conservation of
structure and function will facilitate the identification and
purification of the other proteins involved in DNA replication
in trypanosomes. In yeast and human cells, the middle subunit
of RP-A is subject to cell cycle-dependent phosphorylation
(19). Determination of the phosphorylation state of C. fascic-
ulata RP-A during the cell cycle may indicate if replication
proteins in trypanosomes are subject to the same cell cycle
regulation as their homologues in higher eukaryotes. Finally,
since RP-A functions in the initiation of SV40 replication and
interacts specifically with the viral initiator protein T-Ag (36),
C. fasciculata RP-A will be valuable in studying initiation of
DNA replication in trypanosomes.
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